Hanmi Pharm. Statistics

Total Valuation

Hanmi Pharm. has a market cap or net worth of KRW 4.11 trillion. The enterprise value is 4.55 trillion.

Market Cap	4.11T
Enterprise Value	4.55T

Important Dates

The next estimated earnings date is Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	Jun 27, 2024

Share Statistics

Hanmi Pharm. has 12.68 million shares outstanding. The number of shares has decreased by -0.09% in one year.

Shares Outstanding	12.68M
Shares Change (YoY)	-0.09%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	7.81%
Owned by Institutions (%)	21.56%
Float	6.20M

Valuation Ratios

The trailing PE ratio is 22.33 and the forward PE ratio is 22.05. Hanmi Pharm.'s PEG ratio is 1.60.

PE Ratio	22.33
Forward PE	22.05
PS Ratio	2.62
PB Ratio	3.89
P/FCF Ratio	18.80
PEG Ratio	1.60

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.40, with an EV/FCF ratio of 20.78.

EV / Earnings	24.68
EV / Sales	2.90
EV / EBITDA	12.40
EV / EBIT	16.91
EV / FCF	20.78

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.43.

Current Ratio	1.09
Quick Ratio	0.64
Debt / Equity	0.43
Debt / EBITDA	1.42
Debt / FCF	2.37
Interest Coverage	9.92

Financial Efficiency

Return on equity (ROE) is 18.22% and return on invested capital (ROIC) is 9.87%.

Return on Equity (ROE)	18.22%
Return on Assets (ROA)	8.67%
Return on Capital (ROIC)	9.87%
Revenue Per Employee	690.18M
Profits Per Employee	81.12M
Employee Count	2,273
Asset Turnover	0.82
Inventory Turnover	2.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.96% in the last 52 weeks. The beta is 0.51, so Hanmi Pharm.'s price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	+2.96%
50-Day Moving Average	305,740.00
200-Day Moving Average	313,744.51
Relative Strength Index (RSI)	55.69
Average Volume (20 Days)	94,296

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hanmi Pharm. had revenue of KRW 1.57 trillion and earned 184.38 billion in profits. Earnings per share was 14,533.91.

Revenue	1.57T
Gross Profit	875.17B
Operating Income	266.57B
Pretax Income	242.14B
Net Income	184.38B
EBITDA	364.24B
EBIT	266.57B
Earnings Per Share (EPS)	14,533.91

Full Income Statement

Balance Sheet

The company has 246.89 billion in cash and 518.92 billion in debt, giving a net cash position of -272.03 billion or -21,452.86 per share.

Cash & Cash Equivalents	246.89B
Total Debt	518.92B
Net Cash	-272.03B
Net Cash Per Share	-21,452.86
Equity (Book Value)	1.22T
Book Value Per Share	83,315.27
Working Capital	61.19B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 253.08 billion and capital expenditures -34.17 billion, giving a free cash flow of 218.91 billion.

Operating Cash Flow	253.08B
Capital Expenditures	-34.17B
Free Cash Flow	218.91B
FCF Per Share	17,263.74

Full Cash Flow Statement

Margins

Gross margin is 55.79%, with operating and profit margins of 16.99% and 11.75%.

Gross Margin	55.79%
Operating Margin	16.99%
Pretax Margin	15.44%
Profit Margin	11.75%
EBITDA Margin	23.22%
EBIT Margin	16.99%
FCF Margin	13.95%

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 0.15%.

Dividend Per Share	500.00
Dividend Yield	0.15%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	6
Payout Ratio	4.69%
Buyback Yield	0.09%
Shareholder Yield	0.24%
Earnings Yield	4.48%
FCF Yield	5.32%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.02

Scores

Hanmi Pharm. has an Altman Z-Score of 4.83.

Altman Z-Score	4.83
Piotroski F-Score	n/a